Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories

Go back to Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
Chugai Pharmaceutical Ltd Unsponsored ADR (AMEX: CHGCY) Delayed: 23.26 --0 (-0%)
Previous Close $23.26    52 Week High $74.63 
Open $23.26    52 Week Low $56.80 
Day High $23.26    P/E N/A 
Day Low $23.26    EPS $0.00 
Volume      

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 49.12 --0 (-0%)
Previous Close $49.12    52 Week High $35.13 
Open $49.12    52 Week Low $28.10 
Day High $49.12    P/E N/A 
Day Low $49.12    EPS $0.00 
Volume      

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732